News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,433 Results
Type
Article (14297)
Company Profile (105)
Press Release (260023)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88437)
Career Advice (467)
Deals (15416)
Drug Delivery (73)
Drug Development (36766)
Employer Resources (50)
FDA (6395)
Job Trends (6251)
News (150961)
Policy (14151)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (446)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23360)
ALS (56)
Alzheimer's disease (479)
Antibody-drug conjugate (ADC) (99)
Approvals (6587)
Artificial intelligence (202)
Autoimmune disease (39)
Automation (12)
Bankruptcy (151)
Best Places to Work (4385)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (174)
Cancer (1324)
Cardiovascular disease (151)
Career advice (420)
Career pathing (13)
CAR-T (49)
CDC (6)
Cell therapy (150)
Cervical cancer (9)
Clinical research (32059)
Collaboration (725)
Compensation (325)
Complete response letters (33)
COVID-19 (782)
CRISPR (43)
C-suite (433)
Cystic fibrosis (58)
Data (1825)
Denatured (18)
Depression (45)
Diabetes (126)
Diagnostics (1385)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (113)
Drug pricing (115)
Drug shortages (13)
Duchenne muscular dystrophy (80)
Earnings (33497)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (39070)
Executive appointments (528)
FDA (7495)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (428)
Gene editing (70)
Generative AI (18)
Gene therapy (165)
GLP-1 (439)
Government (1407)
Grass and pollen (4)
Guidances (164)
Healthcare (3595)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (68)
Immuno-oncology (14)
Indications (53)
Infectious disease (848)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (113)
Interviews (61)
IPO (5919)
IRA (33)
Job creations (2059)
Job search strategy (375)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (205)
Leadership (8)
Legal (3452)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (412)
MASH (67)
Medical device (1324)
Medtech (1331)
Mergers & acquisitions (9920)
Metabolic disorders (434)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (82)
Neuropsychiatric disorders (37)
Neuroscience (888)
Neurotech (1)
NextGen: Class of 2026 (1604)
Non-profit (611)
Now hiring (17)
Obesity (227)
Opinion (141)
Ovarian cancer (39)
Pain (109)
Pancreatic cancer (51)
Parkinson's disease (80)
Partnered (11)
Patents (221)
Patient recruitment (116)
Peanut (12)
People (29806)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8319)
Phase 2 (13541)
Phase 3 (12218)
Pipeline (1909)
Policy (135)
Postmarket research (1403)
Preclinical (3343)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (135)
Rare diseases (350)
Real estate (2667)
Recruiting (18)
Regulatory (10972)
Reports (15)
Research institute (577)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (69)
Series A (80)
Series B (48)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1646)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (231)
Venture capital (32)
Weight loss (140)
Women's health (27)
Worklife (4)
Date
Last 7 days (177)
Last 30 days (704)
Last 365 days (10421)
2026 (951)
2025 (10732)
2024 (12512)
2023 (14273)
2022 (19586)
2021 (20110)
2020 (19085)
2019 (14964)
2018 (11765)
2017 (13919)
2016 (13175)
2015 (15497)
2014 (12453)
2013 (10608)
2012 (11414)
2011 (11941)
2010 (10905)
Location
Africa (318)
Alabama (19)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (20910)
Australia (2688)
California (3187)
Canada (1482)
China (550)
Colorado (143)
Connecticut (129)
Delaware (123)
Europe (40926)
Florida (601)
Georgia (63)
Hawaii (1)
Idaho (11)
Illinois (348)
India (44)
Indiana (240)
Iowa (2)
Japan (246)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (421)
Massachusetts (2587)
Michigan (48)
Minnesota (165)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (9)
New Jersey (1396)
New Mexico (7)
New York (907)
North Carolina (623)
North Dakota (2)
Northern California (1451)
Ohio (80)
Oklahoma (5)
Oregon (18)
Pennsylvania (717)
Puerto Rico (12)
Rhode Island (17)
South America (509)
South Carolina (10)
Southern California (1389)
Tennessee (53)
Texas (455)
United States (12692)
Utah (60)
Virginia (160)
Washington D.C. (42)
Washington State (223)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
274,433 Results for "eagle pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
October 21, 2025
·
2 min read
Press Releases
Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements
October 16, 2025
·
1 min read
Press Releases
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
October 6, 2025
·
1 min read
Press Releases
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
August 18, 2025
·
1 min read
Press Releases
Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
August 29, 2025
·
6 min read
Press Releases
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
September 18, 2025
·
1 min read
Press Releases
Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
April 1, 2025
·
8 min read
Business
Eagle Pharmaceuticals Announces Management Change
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced a change in management.
November 29, 2023
·
5 min read
Pharm Country
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today provided an update on its bendamustine intellectual property portfolio.
January 18, 2024
·
7 min read
Pharm Country
Eagle Pharmaceuticals Granted Patent for PEMFEXY®
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the U.S. Patent and Trademark Office has granted the Company U.S. Patent No. 11,793,813 (“the ‘813 patent”) entitled “Pemetrexed Formulations.” Eagle has submitted the patent for listing in the U.S. Food and Drug Administration’s Orange Book.
October 24, 2023
·
5 min read
1 of 27,444
Next
